Matthew H Liang and Peter H Schur

Guest Editors' Foreword
Lupus 1999 8: 569. [PDF]  

Matthew H Liang, Michael Corzillius, Sang-Cheol Bae, Paul Fortin, John M Esdaile, and Michal Abrahamowicz

A conceptual framework for clinical trials in SLE and other multisystem diseases
Lupus 1999 8: 570-580. [PDF] [References]  

J N Siegel

Development of an FDA guidance document for clinical trials in SLE
Lupus 1999 8: 581-585. [Abstract] [PDF] [References]  

E L Smith and R H Shmerling

The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: Strengths, weaknesses, and opportunities for improvement
Lupus 1999 8: 586-595. [Abstract] [PDF] [References]  

S M Edworthy

World Wide Web: Opportunities, challenges, and threats
Lupus 1999 8: 596-605. [Abstract] [PDF] [References]  

Diane Ferland and Paul R Fortin

Recruitment strategies in superiority trials in SLE: lessons from the study of methotrexate in lupus erythematosus (SMILE)
Lupus 1999 8: 606-611. [Abstract] [PDF] [References]  

Andrew D Moore and Lawrence Joseph

Sample size considerations for superiority trials in systemic lupus erythematosus (SLE)
Lupus 1999 8: 612-619. [Abstract] [PDF] [References]  

Mimi Y Kim, Jill P Buyon, Michelle Petri, Mary Louise Skovron, and Roy E Shore

Equivalence trials in SLE research: issues to consider
Lupus 1999 8: 620-626. [Abstract] [PDF] [References]  

M Schneider

Response and remission criteria for clinical trials in lupus— what can we learn from other diseases?
Lupus 1999 8: 627-631. [PDF] [References]  

D D Gladman and Murray B Urowitz

The SLICC/ACR damage index: progress report and experience in the field
Lupus 1999 8: 632-637. [Abstract] [PDF] [References]  

J D Fitzgerald and J M Grossman

Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients
Lupus 1999 8: 638-644. [Abstract] [PDF] [References]  

Caroline Gordon and Ann E Clarke

Quality of life and economic evaluation in SLE clinical trials
Lupus 1999 8: 645-654. [Abstract] [PDF] [References]  

M Corzillius, P Fortin, and G Stucki

Responsiveness and sensitivity to change of SLE disease activity measures
Lupus 1999 8: 655-659. [Abstract] [PDF] [References]  

Jim C Yen, Carolyn Neville, and Paul R Fortin

Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials
Lupus 1999 8: 660-670. [Abstract] [PDF] [References]  

Rosalind Ramsey-Goldman and Karen W Hayes

Ensuring reliability of clinical assessments for SLE trials
Lupus 1999 8: 671-676. [Abstract] [PDF] [References]  

Jill P Buyon, Kenneth C Kalunian, Rosalind Ramsey-Goldman, Michelle A Petri, Michael D Lockshin, Guillermo Ruiz-Irastorza, and Munther Khamashta

Assessing disease activity in SLE patients during pregnancy
Lupus 1999 8: 677-684. [PDF] [References]  

Michelle Petri, Jill Buyon, and Mimi Kim

Classification and definition of major flares in SLE clinical trials
Lupus 1999 8: 685-691. [Abstract] [PDF] [References]  

M Corzillius and S-C Bae

Methodological issues of corticosteroid use in SLE clinical trials
Lupus 1999 8: 692-697. [Abstract] [PDF] [References]  

Michael P LaValley and David T Felson

Early stopping of clinical trials in lupus and other uncommon rheumatologic diseases
Lupus 1999 8: 698-703. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.